Title: Evaluation of 1, 3-Beta-D-Glucan Assay for Diagnosis of Invasive Fungal Infection in Pediatric Cancer Patients

Abstract:

Background & Objective: Serum 1,3-β-D-glucan (BDG) is indicated as a tool for early diagnosis of invasive fungal Infections (IFIs). Although this assay has been evaluated well in adult patients, its role in diagnosis of IFI in paediatric cancer patients is said to be limited. One of the reasons for this could be the cut off value chosen for interpretation of the assay. Different studies have suggested different cut off values to diagnose IFI in adult patients by this assay. Most of the time only single serum samples are available from paediatric cancer patients, also serial testing is not possible due to high cost of the assay. This study was therefore planned with the objective to determine the assays best cut off value for the diagnosis of IFI by single serum samples in paediatric cancer patients.

Biography:

Abrar Ahmad Ph.D Microbiology with 8 years of academic research and 1 year of Industry experience.has research interests in Invasive Fungal Infection.